Biocept Stock Performance
| BIOCQ Stock | 0.0001 0.0001 50.00% |
Biocept holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 13.81, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biocept will likely underperform. Use Biocept variance, kurtosis, as well as the relationship between the Kurtosis and price action indicator , to analyze future returns on Biocept.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Biocept are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental indicators, Biocept reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 28.9 M | |
| Total Cashflows From Investing Activities | -807 K |
Biocept Relative Risk vs. Return Landscape
If you would invest 0.01 in Biocept on September 28, 2025 and sell it today you would earn a total of 0.00 from holding Biocept or generate 0.0% return on investment over 90 days. Biocept is currently producing 14.6923% returns and takes up 125.4675% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Biocept, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Biocept Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biocept's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biocept, and traders can use it to determine the average amount a Biocept's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1171
| Best Portfolio | Best Equity | BIOCQ | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Biocept is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biocept by adding it to a well-diversified portfolio.
Biocept Fundamentals Growth
Biocept Stock prices reflect investors' perceptions of the future prospects and financial health of Biocept, and Biocept fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biocept Stock performance.
| Return On Equity | -1.87 | ||||
| Return On Asset | -0.52 | ||||
| Operating Margin | (10.38) % | ||||
| Current Valuation | 4.96 M | ||||
| Shares Outstanding | 2.63 M | ||||
| Price To Book | 0.29 X | ||||
| Price To Sales | 0.0004 X | ||||
| Revenue | 25.86 M | ||||
| EBITDA | (30.24 M) | ||||
| Total Debt | 12.11 M | ||||
| Book Value Per Share | 0.12 X | ||||
| Cash Flow From Operations | (13.29 M) | ||||
| Earnings Per Share | (96.34) X | ||||
| Total Asset | 30.87 M | ||||
| Retained Earnings | (298.44 M) | ||||
About Biocept Performance
Assessing Biocept's fundamental ratios provides investors with valuable insights into Biocept's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Biocept is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Biocept performance evaluation
Checking the ongoing alerts about Biocept for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biocept help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biocept is way too risky over 90 days horizon | |
| Biocept has some characteristics of a very speculative penny stock | |
| Biocept appears to be risky and price may revert if volatility continues | |
| Biocept has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 25.86 M. Net Loss for the year was (32.09 M) with loss before overhead, payroll, taxes, and interest of (14.3 M). | |
| Biocept generates negative cash flow from operations | |
| Biocept has a poor financial position based on the latest SEC disclosures |
- Analyzing Biocept's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biocept's stock is overvalued or undervalued compared to its peers.
- Examining Biocept's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biocept's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biocept's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biocept's stock. These opinions can provide insight into Biocept's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Biocept Stock Analysis
When running Biocept's price analysis, check to measure Biocept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocept is operating at the current time. Most of Biocept's value examination focuses on studying past and present price action to predict the probability of Biocept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocept's price. Additionally, you may evaluate how the addition of Biocept to your portfolios can decrease your overall portfolio volatility.